How long and how much? Bringing a biotech crop to market costs $116 million and takes 16.5 years

Credit: Shutterstock
Credit: Shutterstock

Farmers are increasingly faced with the need to produce more food from fewer resources and under less predictable growing conditions. They are also tasked with managing the broader landscape within which they farm and mitigating the effects of climate change.

Each year, millions of farmers around the world plant biotech crops for higher yields, improved crop quality, and the ability to use sustainable farming practices such as no-till. Getting these innovative new genetically modified (GM) traits from the lab to their fields requires a tremendous investment from product developers.

  • The good news is that the cost of discovery, development, and authorization of a new GM trait has declined by $21 million over the past 10 years. However, more importantly, the time to get these new innovations to market has increased from 13.1 years to 16.5 years.
  • Despite product developers improving parts of the research and development process, it is taking them longer to realize a return on their investment. And just as important, it is taking longer to get these new innovations into the hands of farmers.
  • This report demonstrates that now more than ever, a more harmonized regulatory framework around the world for GM traits would improve time to market, which promotes innovation and ultimately helps farmers and consumers.
Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

Key findings of the study include

The regulatory phase, the longest duration of the overall process, accounted for almost 40% (37.6%) of the total cost of commercialization and more importantly more than half (51.1%) of the time. This increase in time reflects an increase of almost 140% over the 2008-2012 study and an additional 40 months of lost commercial revenue for product developers.

[Editor’s note: Read the entire report here: Time and Cost to Develop a New GM Trait.]

This is an excerpt. Read the original post here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

eden green vertical farm facility
Why vertical farming is not the panacea for our food production crisis that its proponents claim
Energetic Speaker on Stage
Viewpoint: Why are the stars of the MAHA revolution standing by convicted rapist — and conservative firebrand — Russell Brand?
Professional Portrait Earth Backdrop
Viewpoint: November 13 is the long-predicted global doomsday. How a respected scientist got population growth catastrophe predictions so spectacularly wrong—fueling decades of junk science
Fluorescent and Natural Leaf Comparison
Here’s how biotechnology can reduce threats from disease and pests without resorting to sometimes-problematic chemicals
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ADA Lanyard on Woodgrain Desk
How the Trumpification of medicine is roiling — and maybe destroying—the American Diabetes Association
Watercolor U.S
Cataloging the science-denying road to America losing its global measles-free status
Screenshot-2026-11-12-at-12.18.49-PM
Viewpoint: AI and ‘superspecies’: Bernie Sanders on the American oligarchy’s dangerous plans
Data Center Power and Cost Surge
It’s the ‘juice’: What the AI data center wars are really all about
Tropical Yacht Conversation
Kennedy faces Congressional ethics investigation for accepting massive gifts from anti-vaccine and ketamine wellness grifter
Paper Field Portraits with Distant Barn (1)
Viewpoint: After MAHA-Republican election debacle, controversial campaigner Zen Honeycutt looks to sympathetic Democrats to promote her anti-chemical agenda
Testosterone-and-NATO-Editorial-Collage
Unintended consequences: Hegseth’s proposed controversial ‘low testosterone’ screen could flag 150,000 Army men. What happens next?  
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.